Respiratory Medicine
Volume 103, Issue 9 , Pages 1337-1345 , September 2009

Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease

  • Micha T. Maeder

      Affiliations

    • Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 3 8532 1111; fax: +61 3 8532 1100.
    • ,
  • Martin H. Brutsche

      Affiliations

    • Division of Pneumology, Kantonsspital St. Gallen, Rorschacherstrasse, 9007 St. Gallen, Switzerland
    • ,
  • Andreas Christ

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    • ,
  • Tobias Reichlin

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    • ,
  • Daniel Staub

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    • ,
  • Markus Noveanu

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    • ,
  • Tobias Breidthardt

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    • ,
  • Mihael Potocki

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    • ,
  • Christian Mueller

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland

Received 22 July 2008 ,Accepted 20 March 2009.

References 

  1. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–277
  2. Benzo R, Kelley GA, Recchi L, Hofman A, Sciurba F. Complications of lung resection and exercise capacity: a meta-analysis. Respir Med. 2007;101:1790–1797
  3. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132(Suppl. 3):161S–177S
  4. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol. 2002;40:1531–1540
  5. Arena R, Myers J, Williams MA, et al. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation. 2007;116:329–343
  6. Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol. 2002;40:718–722
  7. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. J Heart Lung Transplant. 2007;26:516–521
  8. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778–786
  9. Leuchte HH, Baumgartner RA, Nounou ME, Vogeser M, Neurohr C, Trautnitz M, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med. 2006;173:744–750
  10. American Thoracic Society . Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1136
  11. Schmid A, Schilter D, Fengels I, et al. Design and validation of an interpretative strategy for cardiopulmonary exercise tests. Respirology. 2007;12:916–923
  12. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem. 2004;50:1104–1106
  13. Karl J, Borgya A, Gallusser A, et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl. 1999;230:177–181
  14. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845
  15. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–167
  16. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357–2368
  17. Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW, et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. Br Med J. 2005;331:1379
  18. Christ-Crain M, Breidthardt T, Stolz D, et al. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia. J Intern Med. 2008 Feb 20;[Epub ahead of print]
  19. Stolz D, Breidthardt T, Christ-Crain M, Bingisser R, Miedinger D, Leuppi J, et al. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease. Chest. 2008;133:1088–1094
  20. Goetze JP, Videbaek R, Boesgaard S, Aldershvile J, Rehfeld JF, Carlsen J. Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. J Heart Lung Transplant. 2004;23:80–87
  21. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008;177:743–751
  22. Benzo RP, Paramesh S, Patel SA, Slivka WA, Sciurba FC. Optimal protocol selection for cardiopulmonary exercise testing in severe COPD. Chest. 2007;132:1500–1505
  23. Christensen CC, Ryg MS, Edvardsen A, Skjonsberg OH. Effect of exercise mode on oxygen uptake and blood gases in COPD patients. Respir Med. 2004;98:656–660
  24. Mathur RS, Revill SM, Vara DD, Walton R, Morgan MD. Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease. Thorax. 1995;50:829–833
  25. Skaluba SJ, Litwin SE. Mechanisms of exercise intolerance. Insights from tissue Doppler imaging. Circulation. 2004;109:972–977
  26. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003;167:735–740

PII: S0954-6111(09)00097-3

doi: 10.1016/j.rmed.2009.03.015

Respiratory Medicine
Volume 103, Issue 9 , Pages 1337-1345 , September 2009

Article Tools

* Image Usage & Resolution